• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Fluorobenzenes
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides
• Solvents and Organic Chemicals Organic Compounds

Introduction to 5-Amino-3-(3-fluorophenyl)isoxazole (CAS No. 119162-50-4)

5-Amino-3-(3-fluorophenyl)isoxazole, identified by its Chemical Abstracts Service (CAS) number 119162-50-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the isoxazole family, a class of molecules characterized by a five-membered ring containing an oxygen atom and a nitrogen atom. The presence of both amino and fluoro substituents in its structure imparts unique chemical and biological properties, making it a promising candidate for further exploration in drug discovery and development.

The structural framework of 5-Amino-3-(3-fluorophenyl)isoxazole consists of an isoxazole core linked to a fluorophenyl group at the 3-position and an amino group at the 5-position. The fluorine atom, being highly electronegative, exerts a significant influence on the electronic properties of the molecule, potentially modulating its reactivity and interactions with biological targets. Similarly, the amino group serves as a versatile functional handle, allowing for further chemical modifications and derivatization to enhance pharmacological activity.

In recent years, there has been a surge in research focused on developing novel therapeutic agents derived from isoxazole scaffolds. The inherent bioactivity of isoxazole derivatives has been demonstrated in various pharmacological contexts, including antimicrobial, anti-inflammatory, and anticancer applications. Among these derivatives, 5-Amino-3-(3-fluorophenyl)isoxazole has emerged as a particularly intriguing compound due to its potential to interact with multiple biological pathways.

One of the most compelling aspects of 5-Amino-3-(3-fluorophenyl)isoxazole is its reported activity against certain enzymatic targets relevant to human diseases. For instance, studies have suggested that this compound may exhibit inhibitory effects on specific kinases and other enzymes implicated in cancer progression. The fluorine substituent at the phenyl ring has been shown to enhance binding affinity and selectivity, which are critical factors in the design of effective small-molecule inhibitors.

Moreover, the amino group in 5-Amino-3-(3-fluorophenyl)isoxazole provides an opportunity for prodrug development or covalent drug-drug interactions. Prodrug strategies leverage functional groups like amines to improve solubility or metabolic stability before converting into the active form within biological systems. This approach can enhance drug delivery and efficacy while minimizing side effects.

The synthesis of 5-Amino-3-(3-fluorophenyl)isoxazole involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include condensation reactions between appropriate precursors followed by functional group transformations such as fluorination and amination. Advances in synthetic methodologies have enabled more efficient production processes, making it feasible to conduct large-scale studies and clinical trials.

Recent advancements in computational chemistry have also played a pivotal role in understanding the molecular interactions of 5-Amino-3-(3-fluorophenyl)isoxazole. Molecular docking simulations and quantum mechanical calculations have provided insights into its binding mode with target proteins, helping researchers refine its structure for improved pharmacological properties. These computational tools are indispensable in modern drug discovery pipelines, allowing for rapid screening of virtual libraries and identification of lead compounds.

In preclinical studies, 5-Amino-3-(3-fluorophenyl)isoxazole has demonstrated promising results in cell-based assays and animal models. Its ability to modulate key signaling pathways has raised hopes for its application in treating diseases such as cancer and inflammatory disorders. However, further research is necessary to fully elucidate its mechanism of action and assess potential toxicities before moving into human clinical trials.

The pharmaceutical industry continues to invest heavily in exploring heterocyclic compounds like isoxazoles due to their diverse biological activities and synthetic accessibility. 5-Amino-3-(3-fluorophenyl)isoxazole stands out as a representative example of how structural modifications can lead to novel therapeutic entities with tailored properties.

As our understanding of disease mechanisms evolves, so does the demand for innovative molecular tools capable of addressing complex pathologies. The continued investigation into compounds like 5-Amino-3-(3-fluorophenyl)isoxazole holds great promise for advancing therapeutic strategies across multiple therapeutic areas.

In conclusion, 5-Amino-3-(3-fluorophenyl)isoxazole (CAS No. 119162-50-4) is a structurally unique compound with significant potential in pharmaceutical research. Its combination of bioactive moieties—amino and fluoro substituents—makes it an attractive candidate for drug development. With ongoing studies exploring its pharmacological profile and synthetic optimization, this molecule exemplifies the importance of heterocyclic chemistry in medicinal innovation.

• 1020955-76-3(3-(3-Fluoro-4-methylphenyl)-1,2-oxazol-5-amine)
• 1020996-82-0(3-(3,5-Difluorophenyl)-1,2-oxazol-5-amine)
• 1021245-66-8(3-(2,6-difluorophenyl)-1,2-oxazol-5-amine)
• 119162-49-1(3-(2-Fluorophenyl)isoxazol-5-amine)
• 81465-82-9(3-(4-Fluorophenyl)isoxazol-5-amine)
• 28883-91-2(3-(p-tolyl)isoxazol-5-amine)
• 1427380-13-9(3-(2,4,6-trifluorophenyl)-1,2-oxazol-5-amine)
• 4369-55-5(3-phenyl-1,2-oxazol-5-amine)
• 1021245-84-0(3-(2,4-Difluorophenyl)isoxazol-5-amine)
• 874376-50-8(3-(3,4-difluorophenyl)-1,2-oxazol-5-amine)